EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

miR-30a enhanced RIG-I-mediated type I interferon antiviral response by targeting USP14

Jikai Zhang iD, Yiwen Wang, Ningye Sun, Botao Zou, Zijie Wang, Hang Yin, Jiaqian Xie, Banruo Xia, Nan Sun iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.00188-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Jikai Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and …. Hauptthemen laut MEDLINE: MicroRNAs, Ubiquitin Thiolesterase, Interferon Type I, DEAD Box Protein 58. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Training Program of Innovation and Entrepreneurship for College Students in Jiangsu Province, Starting Grants for Young Scientist of Xuzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type I interferon (IFN) signaling plays a prominent role in the host innate immune defense against viral infection. The regulatory roles of miRNAs on the innate immune response remain to be further explored. Although miR-30a has been implicated in the regulation of various viral life cycles, the underlying mechanism on type I IFN signaling remains controversial. Herein, miR-30a was identified as a regulator of type 1 IFN production in macrophages. We observed that miR-30a expression was significantly decreased by vesicular stomatitis virus (VSV) or Sendai virus (SeV) infection in THP-1 cells. In return, overexpression of miR-30a promoted viral infection-triggered IFN and ISGs production to inhibit VSV or SeV replication. Mechanistically, miR-30a inhibited USP14 expression by binding with the 3′UTR of mRNA. USP14 was identified as an inhibitor of IFN signaling by removing the K63-linked ubiquitination from RIG-I, as previously reported. Consequently, miR-30a, by downregulating USP14 expression, enhanced the K63-linked ubiquitination of RIG-I to exert broad-spectrum antiviral effects. Overall, this study revealed a novel antiviral mechanism of miR-30a through the miR-30a-USP14-RIG-I axis and enriched miRNA–innate immunity regulatory networks. IMPORTANCE miRNAs are involved in the regulation of innate immune responses and affect the life cycle of viruses. In this study, we identified miR-30a as a potent positive regulator of type I IFN signaling. The further mechanistic study revealed that miR-30a, by targeting and inhibiting USP14 expression, promoted RIG-I K63 ubiquitination to enhance type I IFN responses, thereby resulting in broad-spectrum antiviral effects against multiple viruses. As a complex regulatory network, the activation of type I interferon responses could subsequently reduce miR-30a expression to prevent the dysregulated activation. The insights gained could be crucial for developing innovative antiviral strategies to combat viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsUbiquitin ThiolesteraseInterferon Type IDEAD Box Protein 58HumansImmunity, InnateVesiculovirusSignal TransductionUbiquitinationVirus ReplicationSendai virusTHP-1 CellsMacrophagesReceptors, ImmunologicAntiviral AgentsCell Line

Stichwörter der Autor:innen

RIG-IUSP14antiviral effectsinnate immunitymiR-30aubiquitination

Substanzen

MicroRNAsUbiquitin ThiolesteraseInterferon Type IDEAD Box Protein 58RIGI protein, humanUSP14 protein, humanMIRN30a microRNA, humanReceptors, ImmunologicAntiviral Agents

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, School of Basic Medical Sciences, Xuzhou Medical Universit…
  • Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.

ORCID-Profile: Jikai Zhang, Nan Sun

Förderung

  • National Natural Science Foundation of China
  • Training Program of Innovation and Entrepreneurship for College Students in Jiangsu Province
  • Starting Grants for Young Scientist of Xuzhou Medical University

Zitieren

APA

Zhang, J., Wang, Y., Sun, N., Zou, B., Wang, Z., Yin, H., Xie, J., Xia, B., & Sun, N. (2025). miR-30a enhanced RIG-I-mediated type I interferon antiviral response by targeting USP14. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00188-25

Vancouver

Zhang J, Wang Y, Sun N, Zou B, Wang Z, Yin H, et al. miR-30a enhanced RIG-I-mediated type I interferon antiviral response by targeting USP14. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00188-25

BibTeX
@article{Zhang2025,
  author = {Zhang, Jikai and Wang, Yiwen and Sun, Ningye and Zou, Botao and Wang, Zijie and Yin, Hang and Xie, Jiaqian and Xia, Banruo and Sun, Nan},
  title = {miR-30a enhanced RIG-I-mediated type I interferon antiviral response by targeting USP14},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.00188-25}
}
Kostenlos starten →